Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report) traded down 19.6% during mid-day trading on Friday . The company traded as low as C$0.18 and last traded at C$0.19. 802,183 shares changed hands during trading, an increase of 866% from the average session volume of 83,002 shares. The stock had previously closed at C$0.23.
Nanalysis Scientific Stock Performance
The company has a market capitalization of C$20.95 million, a PE ratio of -1.68 and a beta of -0.75. The business’s 50-day moving average is C$0.24 and its 200-day moving average is C$0.27. The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.11 and a current ratio of 1.42.
Nanalysis Scientific Company Profile
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.
Read More
- Five stocks we like better than Nanalysis Scientific
- How Investors Can Find the Best Cheap Dividend Stocks
- Auto Tariffs Are Coming Down: 3 Stocks to Benefit Soon
- How to Use the MarketBeat Excel Dividend Calculator
- Tencent Music Stock Outshines Spotify as China’s Music Giant
- About the Markup Calculator
- DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy?
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
